Eva Walde

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden.

Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden.

Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden.

Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden.

Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden.